Source-grounded facts extracted from Axil Brands, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Axil Brands, Inc. reported fourth quarter of fiscal 2026 results: revenue $8 million to $10 million. Guidance initiated.
“Fourth Quarter and Fiscal Year 2026 Outlook Based on our current visibility and assumptions regarding continued retail expansion and other factors, we expect revenue for the fourth quarter of fiscal 2026 to be in the range of $8 million to $10 million, representing approximately 39% to 74% year-over-year growth, with gross margins for the fourth quarter of fiscal 2026 to be”
Axil Brands, Inc. reported third fiscal quarter ended February 28, 2026 results: revenue $7.3 million, net income $0.2 million, EPS $0.02 per diluted share.
“results for the third fiscal quarter ended February 28, 2026 (“Q3 2026”). Financial Highlights for the Quarter Ended February 28, 2026 · Net sales increased 5.4% in Q3 2026 to $7.3 million, compared to $6.9 million in the prior year period · Gross profit was largely unchanged at approximately $5.0 million for both periods, representing 69.1% gross margin in Q3”
Axil Brands, Inc.: Decreased authorized shares of common stock from 450,000,000 to 15,000,000, preferred stock from 300,000,000 to 28,000,000, and Series A Preferred from 250,000,000 to 27,773,500 (effective 2025-05-19).
“On May 19, 2025, AXIL Brands, Inc. (the “Company”) filed a Certificate of Amendment to the Amended and Restated Certificate of Incorporation (“Certificate of Amendment”) with the Delaware Secretary of State to decrease the number of authorized shares of the Company’s common stock, par value $0.0001 per share, from 450,000,000 shares to 15,000,000 shares and to decrease the number of authorized shares of the Company’s preferred stock, par value $0.0001 per share, from 300,000,000 shares to 28,000,000 shares and correspondingly decrease the number of shares of preferred stock designated as Series A Preferred Stock from 250,000,000 shares to 27,773,500 shares, which was effective upon filing.”
Monica Diaz Brickell departed as Chief Financial Officer at Axil Brands, Inc..
“As previously announced, effective April 30, 2024, Monica Diaz Brickell left AXIL Brands, Inc. (the “Company”), including her position as the Chief Financial Officer of the Company.”
Jeff Brown was appointed as Chief Financial Officer and Chief Operating Officer at Axil Brands, Inc..
“appointed Jeff Brown, Chief Operating Officer of the Company, as Chief Financial Officer and Chief Operating Officer of the Company, effective as of May 1, 2024.”
Monica Diaz Brickell departed as Chief Financial Officer at Axil Brands, Inc..
“Effective April 30, 2024, Monica Diaz Brickell left the Company, including her position as the Chief Financial Officer of the Company.”
Axil Brands, Inc. entered into Repurchase Agreements with stockholders of the Company listed on the signature pages valued at $1,246,489.50 (effective 2024-03-05).
“Effective as of March 5, 2024, AXIL Brands, Inc. (the “Company”) entered into repurchase agreements (the “Repurchase Agreements”) with the stockholders of the Company listed on the signature pages thereto (the “Stockholders”) to purchase from the Stockholders in the aggregate 207,748,250 shares of Series A Preferred Stock of the Company (equivalent, in the aggregate, to approximately 10,387,413 shares of the Company’s common stock on an as converted basis) for the aggregate cash consideration of $1,246,489.50.”
Axil Brands, Inc.: Created classified board with three classes and amended bylaws to establish advance notice procedures for stockholder nominations and proposals (effective 2024-02-14).
“The Charter Amendment will also increase the size of the Board of Directors (the “Board”) of the Company and to create three (3) classes of directorships to the Board (the “Classified Board Amendment”), as well as vest with the Board the authority to make, repeal, alter, amend or rescind any or all of the Company’s Bylaws (the “Charter Bylaws Amendment”).”
Axil Brands, Inc.: Company changed name from Reviv3 Procare Company to AXIL Brands, Inc. via Certificate of Amendment (effective 2024-02-14).
“On February 12, 2024, Reviv3 Procare Company (the “Company”) filed a Certificate of Amendment (the “Charter Amendment”) to the Company’s Amended and Restated Certificate of Incorporation with the Delaware Secretary of State, which will become effective at 12:01 a.m. Eastern Time on February 14, 2024”
Manu Ohri was appointed as Director at Axil Brands, Inc..
“appointed Jeffrey Brown, Peter Dunne, and Manu Ohri to the Board”
Peter Dunne was appointed as Director at Axil Brands, Inc..
“appointed Jeffrey Brown, Peter Dunne, and Manu Ohri to the Board”
Jeffrey Brown was appointed as Director at Axil Brands, Inc..
“appointed Jeffrey Brown, Peter Dunne, and Manu Ohri to the Board”
Axil Brands, Inc.: Filed a Certificate of Amendment to effect a 1-for-20 reverse stock split of common stock (effective 2024-01-16).
“On January 12, 2024, Reviv3 Procare Company (the “Company”) filed a Certificate of Amendment (the “Amendment”) to the Company’s Amended and Restated Certificate of Incorporation, with the Delaware Secretary of State to implement a reverse stock split of the Company’s issued shares of common stock, par value $0.0001 per share at a ratio of one (1) for twenty (20) approved by the Company’s Board of Directors, effective at 12:01 a.m. Eastern Time on January 16, 2024 (the “Reverse Stock Split”).”
Axil Brands, Inc. reported the second quarter ended November 30, 2023 results: revenue $8.4 million, net income $1,018,075.
“2 rviv-20240104_8kex99z1.htm EXHIBIT 99.1 REVIV3 Procare Company Reports Record Second Quarter Fiscal Year 2024 Financial Results Net Sales (revenue) increased 25.1% to a record $8.4 million for the second quarter ended November 30, 2023, as compared to the prior year period. Gross Profit (as a percentage of Net Sales) was 74.3% as compared to 74.9% for the prior”
Axil Brands, Inc. reported financial results for the three months ended August 31, 2023.
“On October 13, 2023, Reviv3 Procare Company (the “Company”) issued a press release announcing its consolidated financial results for the three months ended August 31, 2023.”
Axil Brands, Inc.: Adopted a Code of Business Conduct and Ethics (effective 2023-08-24).
“On August 24, 2023, the Board of Directors of Reviv3 Procare Company (the “Company”) approved a Code of Business Conduct and Ethics to assist its officers, directors, employees and other covered persons in guiding their conduct to enhance the reputation of the Company, and to help foster a culture of honesty and accountability.”
Axil Brands, Inc. reported financial results for the fiscal year ended May 31, 2023.
“On August 22, 2023, Reviv3 Procare Company (the “Company”) issued a press release announcing its consolidated financial results for the fourth quarter ended May 31, 2023.”
Monica Diaz Brickell was appointed as Chief Financial Officer at Axil Brands, Inc..
“On April 24, 2023, the Company appointed Monica Diaz Brickell, aged 44, to serve as the Company’s Chief Financial Officer.”
Meenu Jain resigned as Chief Financial Officer at Axil Brands, Inc..
“On April 21, 2023, Meenu Jain notified Reviv3 Procare Company (the “Company”) that she will be stepping down as Chief Financial Officer of the Company effective at 4:00 p.m. (Pacific Time) on April 21, 2023, for personal reasons.”
Axil Brands, Inc. entered into Securities Purchase Agreements with accredited investors valued at $447,850.25 (effective 2023-02-23).
“On February 23, 2023, Reviv3 Procare Company (the “Company”), a Delaware corporation, issued in private placements to accredited investors an aggregate of 1,947,175 shares of its common stock, par value $0.0001 per share. The securities were issued at a purchase price of $0.23 per share for aggregate gross proceeds to the Company of $447,850.25.”
Axil Brands, Inc. reported second fiscal quarter ended November 30, 2022 results: revenue $6.7 million, net income $987,944.
“Reviv3 Procare Delivers Record Second Quarter Fiscal 2023 Revenue and Earnings · Record second quarter 2023 revenues of $6.7 million, up 1,264% year-over-year. · Gross profit increased to $5.0 million compared to $0.4 million for the prior year quarter. · Net cash generated from operating activities of $2.2 million with a net increase in cash of over $3.6 million for the first six months of 2023. · Net income before provisions for income tax of $987,944 compared to $28,201 in the prior year quarter.”
Axil Brands, Inc. amended Voting Agreement Amendment with Intrepid Global Advisors, Inc. valued at Amendment to Voting Agreement to revise securities exempted from term "New Securities" (effective 2022-11-07).
“Effective as of November 7, 2022, Reviv3 Procare Company (the “Company”) entered into an amendment (the “Amendment”) to the Voting Agreement, effective as of June 16, 2022 (the “Voting Agreement”), by and among the Company, Intrepid Global Advisors, Inc. (“Intrepid), and Axil & Associated Brands Corp. (“Axil”), to revise the securities exempted from the term “New Securities,” as defined in the Voting Agreement.”
Christopher Go changed role as Secretary at Axil Brands, Inc..
“Effective as of November 1, 2022, Christopher Go will continue to serve as Secretary of the Company.”
Meenu Jain was appointed as Chief Financial Officer at Axil Brands, Inc..
“Effective November 1, 2022, Reviv3 Procare Company (the “Company”) its Board of Directors (the “Board”) appointed Meenu Jain as Chief Financial Officer of the Company, succeeding Christopher Go in such position.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.